MERK•G has built a highly innovative pipeline with programs in all phases of preclinical and clinical development, addressing indications within the therapeutic areas of ophthalmology, oncology, and inflammatory disease. In addition to developing candidates independently, MERK•G collaborates with leading pharmaceutical companies including Alcon Research and Baxter.